Search for: "Pfizer Inc."
Results 1281 - 1300
of 1,379
Sorted by Relevance
|
Sort by Date
16 Nov 2010, 5:45 am
The court relied heavily on Pfizer, Inc. v. [read post]
5 Aug 2010, 11:03 am
The largest Healthcare fraud settlement in U.S. history, against Pfizer Inc., paid six whistleblowers more than $102 million. [read post]
21 Jun 2010, 9:57 am
Inc.), Merck Sharp & Dohme B.V. and Merck Sharp & Dohme is upon us. [read post]
19 Mar 2012, 5:50 am
Pfizer, Inc., 2012 WL 859729 (E.D.N.Y. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
9 Aug 2011, 4:30 am
Pfizer, 232 F.R.D. 360 (C.D. [read post]
26 Mar 2012, 1:43 am
Circuit’s 1999 decision in Pfizer Inc. v. [read post]
7 Apr 2008, 2:56 pm
According to Gregg Engles, former lawyer and current CEO of Dean Foods, Inc., the discrepancy is simple. [4] "Many lawyers let knowledge of risk paralyze them. [read post]
20 Jun 2023, 5:55 am
Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUAs) for the Pfizer, Inc. and the ModernaTX, Inc. [read post]
27 Mar 2018, 4:00 am
Pfizer Canada Inc. 2017 FC 826, the Federal Court said that the funding agreement is privileged and refused to order disclosure of the complete unredacted agreement to the defendant. [read post]
17 Dec 2009, 11:22 am
Pfizer, 562 F.3d 163 (2d Cir. 2009). [read post]
17 Mar 2009, 12:50 pm
This warning procedure was outlined in Est’ee Lauder, Inc. v. [read post]
28 Oct 2011, 7:00 am
Pfizer, Inc., 358 F.3d 659, 661 (9th Cir. 2004) (“the doctor who prescribed [the drug] . . . failed to read [the defendant’s] published warnings before prescribing the drug. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over… [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
26 Jun 2024, 8:30 am
Another example of an FBR case in which incarceration was ordered for conduct that was as or less serious compared with Trump’s case: Pfizer Inc. [read post]
11 Apr 2014, 7:41 am
STERN v. [read post]
22 May 2014, 5:00 am
Pfizer, Inc., 2000 WL 1099884, at *2 & n.1 (S.D.N.Y. [read post]
27 Feb 2014, 6:00 am
We watched some of the recently concluded Winter Olympics. [read post]
24 Nov 2015, 12:38 pm
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), and the rest of the First Circuit’s Neurontin trilogy, which took the top spot in our list of worst decisions of 2013. [read post]
